These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 1718453
21. Interleukin-3 dependent mitogenesis in murine cells involves a predominant non-protein kinase C (pKC) dependent pathway for c-myc transcription. Role of a myc expression vector in rescuing pKC dependent mitogenesis. Nahreini TS, Litz-Jackson S, Burgess GS, Helvering LM, Manolagas SC, Boswell HS. Leukemia; 1991 Dec; 5(12):1099-109. PubMed ID: 1774959 [Abstract] [Full Text] [Related]
26. Cell-cycle progression is not essential for c-Myc to block differentiation. Ryan KM, Birnie GD. Oncogene; 1997 Jun 12; 14(23):2835-43. PubMed ID: 9190900 [Abstract] [Full Text] [Related]
27. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation. Dolnikov A, Millington M, Sun LQ, Symonds G. Cancer Gene Ther; 2000 Nov 12; 7(11):1491-503. PubMed ID: 11129291 [Abstract] [Full Text] [Related]
29. Human IL-3 induction of c-jun in normal monocytes is independent of tyrosine kinase and involves protein kinase C. Mufson RA, Szabo J, Eckert D. J Immunol; 1992 Feb 15; 148(4):1129-35. PubMed ID: 1737930 [Abstract] [Full Text] [Related]
30. Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Gerhauser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC, Pezzuto JM. Cancer Res; 1997 Aug 15; 57(16):3429-35. PubMed ID: 9270009 [Abstract] [Full Text] [Related]
31. Activation of junB and c-myc primary response genes by interleukin 9 in a human factor-dependent cell line. Kang LY, Yang YC. J Cell Physiol; 1995 Jun 15; 163(3):623-30. PubMed ID: 7775604 [Abstract] [Full Text] [Related]
32. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3 dependent cell line. McCubrey JA, Steelman LS, McKearn JP. Oncogene Res; 1991 Jun 15; 6(1):1-12. PubMed ID: 1705318 [Abstract] [Full Text] [Related]
34. Tyrosine protein phosphorylation is required for protein kinase C-mediated proliferation in T cells. Muñoz E, Zubiaga AM, Huber BT. FEBS Lett; 1991 Feb 25; 279(2):319-22. PubMed ID: 1705899 [Abstract] [Full Text] [Related]
35. Regulation of ornithine decarboxylase gene expression in normal and transformed hamster embryo fibroblasts following stimulation by 12-O-tetradecanoylphorbol-13-acetate. Gilmour SK, O'Brien TG. Carcinogenesis; 1989 Jan 25; 10(1):157-62. PubMed ID: 2642750 [Abstract] [Full Text] [Related]
36. The proto-oncogene c-myc blocks myeloid differentiation independently of its target gene ornithine decarboxylase. Selvakumaran M, Liebermann D, Hoffman B. Blood; 1996 Aug 15; 88(4):1248-55. PubMed ID: 8695842 [Abstract] [Full Text] [Related]
37. Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes. Nickel KP, Belury MA. Cancer Lett; 1999 Jun 01; 140(1-2):105-11. PubMed ID: 10403548 [Abstract] [Full Text] [Related]
38. Protein kinase C regulation of IEC-6 cell ornithine decarboxylase. Groblewski GE, Ways DK, Seidel ER. Am J Physiol; 1992 Nov 01; 263(5 Pt 1):G742-9. PubMed ID: 1443149 [Abstract] [Full Text] [Related]
39. Interleukin-1-induced growth inhibition of human melanoma cells. Interleukin-1-induced antizyme expression is responsible for ornithine decarboxylase activity down-regulation. Yang D, Hayashi H, Takii T, Mizutani Y, Inukai Y, Onozaki K. J Biol Chem; 1997 Feb 07; 272(6):3376-83. PubMed ID: 9013579 [Abstract] [Full Text] [Related]